SERUM SIALIC-ACID AND CARCINOEMBRYONIC LEVELS IN THE DETECTION AND MONITORING OF COLORECTAL-CANCER

被引:36
作者
VERAZIN, G
RILEY, WM
GREGORY, J
TAUTU, C
PROROK, JJ
ALHADEFF, JA
机构
[1] LEHIGH VALLEY HOSP CTR,DEPT SURG,ALLENTOWN,PA
[2] LEHIGH UNIV,DEPT CHEM,DIV BIOCHEM SCI,BETHLEHEM,PA 18015
关键词
CEA; Colorectal cancer; Sialic acid;
D O I
10.1007/BF02055544
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Total sialic acid (TSA), total protein (TP), TSA normalized to total TP (TSA/TP), and carcinoembryonic antigen levels were determined in 146 consecutive colorectal patients. These results were compared with results from 73 people with nonmalignant gastrointestinal disease, and with results from 96 normal controls. All malignancies were staged according to the Astler-Coller modification of Dukes' classification for colorectal cancer. All blood samples were drawn before surgical therapy. The TSA/TP ratio for colorectal cancer was 13.4 (mg/gm) in contrast to 12.1 (mg/gm) for pathologic controls, and 9.7 (mg/gm) for normal controls. Student'sttest showed aPvalue less than 0.001 for normal controls and aPvalue less than 0.001 for pathologic controls. The TSA/TP also showed statistical significance in Dukes A, B2, C, and D subgroups when compared with normal controls. There were only four patients with stage Cl carcinoma, thus statistical analysis would be questionable. In contrast, carcinoembryonic antigen levels showed no significant elevations until Dukes C2 tumors were encountered. These preliminary findings suggest that TSA/TP ratio may detect colorectal cancer patients with less tumor burden and be more beneficial as a tumor marker than CEA for monitoring patients with colorectal cancer. © 1990 American Society of Colon and Rectal Surgeons.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 31 条
[1]  
DITTRICH C, 1985, CANCER DETECT PREV, V8, P181
[2]  
DNISTRIAN AM, 1981, CLIN CHEM, V27, P1737
[3]  
DNISTRIAN AM, 1982, CANCER, V50, P1815, DOI 10.1002/1097-0142(19821101)50:9<1815::AID-CNCR2820500927>3.0.CO
[4]  
2-H
[5]  
DRISTRIAN A, 1987, ONCOL ROUNDS JUN, P1
[6]  
ERBIL KM, 1985, CANCER, V55, P404, DOI 10.1002/1097-0142(19850115)55:2<404::AID-CNCR2820550219>3.0.CO
[7]  
2-Q
[8]  
GEELHOED GW, UNPUB CLIN UTILITY T
[9]  
GO VLW, 1982, CANCER, V50, P2618
[10]   DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+